

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.89438523 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57603065 |
| 3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.36389612 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.05727408 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.05727408 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.04647187 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 5.04647187 |
| 8 | regulation of cilium movement (GO:0003352) | 4.97555103 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89277069 |
| 10 | respiratory electron transport chain (GO:0022904) | 4.74875152 |
| 11 | cullin deneddylation (GO:0010388) | 4.69530288 |
| 12 | electron transport chain (GO:0022900) | 4.66807326 |
| 13 | proteasome assembly (GO:0043248) | 4.53931526 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.45229026 |
| 15 | protein deneddylation (GO:0000338) | 4.32514429 |
| 16 | chaperone-mediated protein transport (GO:0072321) | 4.30079756 |
| 17 | respiratory chain complex IV assembly (GO:0008535) | 4.26222137 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.22874080 |
| 19 | leukocyte aggregation (GO:0070486) | 4.19480103 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.11341613 |
| 21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.06417804 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.02467138 |
| 23 | protein complex biogenesis (GO:0070271) | 4.00559161 |
| 24 | ribosomal small subunit assembly (GO:0000028) | 3.90910097 |
| 25 | cytochrome complex assembly (GO:0017004) | 3.87804497 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.83390876 |
| 27 | aldehyde catabolic process (GO:0046185) | 3.81274110 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.79552255 |
| 29 | axonemal dynein complex assembly (GO:0070286) | 3.77064104 |
| 30 | oxidative phosphorylation (GO:0006119) | 3.76562069 |
| 31 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.74289012 |
| 32 | negative regulation of ligase activity (GO:0051352) | 3.73829445 |
| 33 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.73829445 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72036240 |
| 35 | protein neddylation (GO:0045116) | 3.68202520 |
| 36 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.65351947 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.62340316 |
| 38 | type I interferon signaling pathway (GO:0060337) | 3.62340316 |
| 39 | response to type I interferon (GO:0034340) | 3.61873304 |
| 40 | response to interferon-beta (GO:0035456) | 3.59096872 |
| 41 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.58579979 |
| 42 | sequestering of actin monomers (GO:0042989) | 3.52000322 |
| 43 | neurotransmitter uptake (GO:0001504) | 3.48076951 |
| 44 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.46875594 |
| 45 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.45543337 |
| 46 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.45543337 |
| 47 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.45397213 |
| 48 | NADH dehydrogenase complex assembly (GO:0010257) | 3.45397213 |
| 49 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.45397213 |
| 50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.45151182 |
| 51 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.45151182 |
| 52 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.45151182 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44167845 |
| 54 | epithelial cilium movement (GO:0003351) | 3.41292891 |
| 55 | actin nucleation (GO:0045010) | 3.37957081 |
| 56 | ATP biosynthetic process (GO:0006754) | 3.35621332 |
| 57 | cilium movement (GO:0003341) | 3.32618301 |
| 58 | respiratory burst (GO:0045730) | 3.32517585 |
| 59 | positive regulation of macrophage differentiation (GO:0045651) | 3.30500812 |
| 60 | neutrophil activation (GO:0042119) | 3.26978366 |
| 61 | regulation of mitochondrial translation (GO:0070129) | 3.25940852 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.25868997 |
| 63 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.25319686 |
| 64 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.25174635 |
| 65 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.25027191 |
| 66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.25027191 |
| 67 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.23386309 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.22977582 |
| 69 | cellular response to interferon-beta (GO:0035458) | 3.20889633 |
| 70 | hepatocyte apoptotic process (GO:0097284) | 3.20284491 |
| 71 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.19659092 |
| 72 | platelet dense granule organization (GO:0060155) | 3.19646365 |
| 73 | hydrogen ion transmembrane transport (GO:1902600) | 3.19384987 |
| 74 | establishment of integrated proviral latency (GO:0075713) | 3.19115281 |
| 75 | negative thymic T cell selection (GO:0045060) | 3.18606728 |
| 76 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.18074774 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.17992154 |
| 78 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.17481930 |
| 79 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.14843333 |
| 80 | termination of RNA polymerase III transcription (GO:0006386) | 3.14843333 |
| 81 | defense response to protozoan (GO:0042832) | 3.14448476 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14091972 |
| 83 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.13759950 |
| 84 | negative T cell selection (GO:0043383) | 3.13295310 |
| 85 | interferon-gamma production (GO:0032609) | 3.12864358 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12165533 |
| 87 | axoneme assembly (GO:0035082) | 3.08314719 |
| 88 | nonmotile primary cilium assembly (GO:0035058) | 3.07978061 |
| 89 | proton transport (GO:0015992) | 3.07367067 |
| 90 | granulocyte activation (GO:0036230) | 3.07242183 |
| 91 | rRNA modification (GO:0000154) | 3.05927587 |
| 92 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.05664651 |
| 93 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05494008 |
| 94 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05494008 |
| 95 | T cell migration (GO:0072678) | 3.04702961 |
| 96 | viral transcription (GO:0019083) | 3.03748148 |
| 97 | cellular response to zinc ion (GO:0071294) | 3.03617659 |
| 98 | hydrogen transport (GO:0006818) | 3.03499697 |
| 99 | positive regulation of ligase activity (GO:0051351) | 3.03345836 |
| 100 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.03276439 |
| 101 | signal peptide processing (GO:0006465) | 3.00950557 |
| 102 | response to protozoan (GO:0001562) | 3.00547652 |
| 103 | NIK/NF-kappaB signaling (GO:0038061) | 3.00107970 |
| 104 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.00059061 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.99807776 |
| 106 | dendritic cell chemotaxis (GO:0002407) | 2.98887872 |
| 107 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98357629 |
| 108 | response to peptidoglycan (GO:0032494) | 2.98339068 |
| 109 | mast cell activation (GO:0045576) | 2.98085237 |
| 110 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.97237656 |
| 111 | intraciliary transport (GO:0042073) | 2.95863996 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 2.95676608 |
| 113 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.95277647 |
| 114 | protein targeting to mitochondrion (GO:0006626) | 2.93910067 |
| 115 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91161794 |
| 116 | hyperosmotic salinity response (GO:0042538) | 2.91021227 |
| 117 | regulation of respiratory burst (GO:0060263) | 2.90854574 |
| 118 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.90704490 |
| 119 | cellular extravasation (GO:0045123) | 2.89013857 |
| 120 | regulation of microtubule-based movement (GO:0060632) | 2.86054777 |
| 121 | regulation of T cell tolerance induction (GO:0002664) | 2.85761559 |
| 122 | leukocyte cell-cell adhesion (GO:0007159) | 2.84702485 |
| 123 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84021640 |
| 124 | regulation of RIG-I signaling pathway (GO:0039535) | 2.83247560 |
| 125 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82494726 |
| 126 | positive regulation of interferon-alpha production (GO:0032727) | 2.82278040 |
| 127 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.82261692 |
| 128 | translational termination (GO:0006415) | 2.81617384 |
| 129 | C4-dicarboxylate transport (GO:0015740) | 2.80706237 |
| 130 | cellular response to interleukin-15 (GO:0071350) | 2.80301501 |
| 131 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.79126844 |
| 132 | presynaptic membrane assembly (GO:0097105) | 2.78897429 |
| 133 | B cell mediated immunity (GO:0019724) | 2.78692789 |
| 134 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.77355590 |
| 135 | protein targeting to ER (GO:0045047) | 2.77149680 |
| 136 | cotranslational protein targeting to membrane (GO:0006613) | 2.76887455 |
| 137 | protein localization to mitochondrion (GO:0070585) | 2.76582681 |
| 138 | regulation of cellular amine metabolic process (GO:0033238) | 2.75950263 |
| 139 | mannosylation (GO:0097502) | 2.74583654 |
| 140 | response to interferon-alpha (GO:0035455) | 2.74433134 |
| 141 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.74321631 |
| 142 | establishment of protein localization to mitochondrion (GO:0072655) | 2.73668224 |
| 143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.73615863 |
| 144 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.73492633 |
| 145 | glutathione derivative biosynthetic process (GO:1901687) | 2.71969263 |
| 146 | glutathione derivative metabolic process (GO:1901685) | 2.71969263 |
| 147 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.71608618 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.71346827 |
| 149 | branched-chain amino acid catabolic process (GO:0009083) | 2.70706376 |
| 150 | dendritic cell migration (GO:0036336) | 2.70236159 |
| 151 | DNA deamination (GO:0045006) | 2.69613416 |
| 152 | regulation of ligase activity (GO:0051340) | 2.68420361 |
| 153 | regulation of interferon-alpha production (GO:0032647) | 2.68305160 |
| 154 | response to interleukin-15 (GO:0070672) | 2.67770897 |
| 155 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.66916477 |
| 156 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.66765122 |
| 157 | regulation of response to interferon-gamma (GO:0060330) | 2.66408700 |
| 158 | cellular response to leptin stimulus (GO:0044320) | 2.66180287 |
| 159 | establishment of viral latency (GO:0019043) | 2.65416736 |
| 160 | protein localization to endoplasmic reticulum (GO:0070972) | 2.64921965 |
| 161 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.64571595 |
| 162 | lactate metabolic process (GO:0006089) | 2.64353068 |
| 163 | mature B cell differentiation involved in immune response (GO:0002313) | 2.63979057 |
| 164 | postsynaptic membrane organization (GO:0001941) | 2.63107972 |
| 165 | ribosomal small subunit biogenesis (GO:0042274) | 2.62428032 |
| 166 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.62407104 |
| 167 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.62407104 |
| 168 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.62366024 |
| 169 | spliceosomal snRNP assembly (GO:0000387) | 2.61824040 |
| 170 | protein-cofactor linkage (GO:0018065) | 2.60723105 |
| 171 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.60695395 |
| 172 | leukocyte degranulation (GO:0043299) | 2.59430767 |
| 173 | intracellular protein transmembrane import (GO:0044743) | 2.59403062 |
| 174 | positive regulation of lamellipodium assembly (GO:0010592) | 2.59350223 |
| 175 | mature B cell differentiation (GO:0002335) | 2.58663529 |
| 176 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.57851095 |
| 177 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.57825486 |
| 178 | protein heterotetramerization (GO:0051290) | 2.57161646 |
| 179 | GPI anchor biosynthetic process (GO:0006506) | 2.57104243 |
| 180 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56493131 |
| 181 | negative regulation of viral genome replication (GO:0045071) | 2.55413986 |
| 182 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.53963291 |
| 183 | regulation of tolerance induction (GO:0002643) | 2.52406752 |
| 184 | barbed-end actin filament capping (GO:0051016) | 2.52005108 |
| 185 | regulation of natural killer cell differentiation (GO:0032823) | 2.51322089 |
| 186 | positive regulation of interleukin-2 production (GO:0032743) | 2.50041698 |
| 187 | negative regulation of phagocytosis (GO:0050765) | 2.49879963 |
| 188 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.49697357 |
| 189 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.49523310 |
| 190 | myeloid cell activation involved in immune response (GO:0002275) | 2.48851717 |
| 191 | response to muramyl dipeptide (GO:0032495) | 2.47326803 |
| 192 | dendritic cell differentiation (GO:0097028) | 2.47207872 |
| 193 | regulation of necrotic cell death (GO:0010939) | 2.45903906 |
| 194 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.45779016 |
| 195 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.45029031 |
| 196 | B cell receptor signaling pathway (GO:0050853) | 2.44882738 |
| 197 | positive regulation of B cell differentiation (GO:0045579) | 2.44429436 |
| 198 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.43161862 |
| 199 | natural killer cell activation (GO:0030101) | 2.43150539 |
| 200 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.41944420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.73357201 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.97806039 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.90063112 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.57602648 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.51988926 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.34412920 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.80978022 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59356780 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53426891 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.49405182 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41428601 |
| 12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.18669490 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.07540369 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.97337166 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.96061185 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84492661 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80893641 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.79921946 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78051675 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68880227 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61345769 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.59577648 |
| 23 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54835921 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.52752026 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.49115935 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.46738613 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43870698 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.43783896 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.38942135 |
| 30 | * MYB_26560356_Chip-Seq_TH2_Human | 2.31748682 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29390696 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.24289500 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13036753 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07938008 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07039698 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 2.04606616 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.02933410 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99627461 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.98411199 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.96621842 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96162377 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90027633 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88551188 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86387818 |
| 45 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85971984 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.84193078 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82689291 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78988327 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78060034 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75497103 |
| 51 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72889438 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71741937 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69156591 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69108853 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.66716805 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66410103 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63853502 |
| 58 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62660239 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61316481 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60730332 |
| 61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.59841591 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57429947 |
| 63 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57212562 |
| 64 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56897149 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56459302 |
| 66 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56273906 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56032340 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51144851 |
| 69 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51074855 |
| 70 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.51063661 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50015383 |
| 72 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49877967 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49578385 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49341936 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48492162 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48449512 |
| 77 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48044566 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47867719 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47444424 |
| 80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.47293919 |
| 81 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46064067 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45798974 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44980304 |
| 84 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.44663162 |
| 85 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44190291 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43172777 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43072655 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41829359 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41828640 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41616286 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38817716 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35844860 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35785123 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35582917 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35394040 |
| 96 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.32471130 |
| 97 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31540587 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30898521 |
| 99 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.30815789 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30212386 |
| 101 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30041392 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29747499 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29708025 |
| 104 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29552090 |
| 105 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28963906 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28728966 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28215882 |
| 108 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.26867646 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26387873 |
| 110 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26200849 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.26075575 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24547741 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.23623848 |
| 114 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16515282 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16321353 |
| 116 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.15883692 |
| 117 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14519978 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14053009 |
| 119 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14046345 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.13815678 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13765057 |
| 122 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12748508 |
| 123 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11554554 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11554554 |
| 125 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10123412 |
| 126 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.09819379 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09140795 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08717926 |
| 129 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05935063 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05773069 |
| 131 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04811367 |
| 132 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04752582 |
| 133 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04752582 |
| 134 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04145987 |
| 135 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03624376 |
| 136 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03202301 |
| 137 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02395197 |
| 138 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02072375 |
| 139 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02070909 |
| 140 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01935725 |
| 141 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01782432 |
| 142 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01058560 |
| 143 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98558719 |
| 144 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97595549 |
| 145 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96782737 |
| 146 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96045164 |
| 147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96037144 |
| 148 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95659024 |
| 149 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95567894 |
| 150 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94678925 |
| 151 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94608298 |
| 152 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94608298 |
| 153 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93913759 |
| 154 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93832201 |
| 155 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93338252 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93199427 |
| 157 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.92978786 |
| 158 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.92937872 |
| 159 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92707450 |
| 160 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92677671 |
| 161 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92570725 |
| 162 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92415292 |
| 163 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92293686 |
| 164 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92096543 |
| 165 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91376899 |
| 166 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91352073 |
| 167 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90712495 |
| 168 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90712495 |
| 169 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90360981 |
| 170 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90299958 |
| 171 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90001281 |
| 172 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89861584 |
| 173 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89268661 |
| 174 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88264660 |
| 175 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88181892 |
| 176 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87088134 |
| 177 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86985885 |
| 178 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86758769 |
| 179 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86532457 |
| 180 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85844224 |
| 181 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85680660 |
| 182 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85577890 |
| 183 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83929388 |
| 184 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82027376 |
| 185 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.81786857 |
| 186 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.76641202 |
| 187 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76162242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.23750152 |
| 2 | MP0009785_altered_susceptibility_to | 3.64777400 |
| 3 | MP0003724_increased_susceptibility_to | 3.63265156 |
| 4 | MP0001984_abnormal_olfaction | 3.54769440 |
| 5 | MP0005671_abnormal_response_to | 3.33391218 |
| 6 | MP0000685_abnormal_immune_system | 3.22779040 |
| 7 | MP0003880_abnormal_central_pattern | 3.22363920 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.17074233 |
| 9 | MP0008789_abnormal_olfactory_epithelium | 3.16866694 |
| 10 | MP0003436_decreased_susceptibility_to | 2.91436456 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.83846710 |
| 12 | MP0005025_abnormal_response_to | 2.79636314 |
| 13 | MP0002736_abnormal_nociception_after | 2.71588579 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.69814526 |
| 15 | MP0001790_abnormal_immune_system | 2.68172796 |
| 16 | MP0005387_immune_system_phenotype | 2.68172796 |
| 17 | MP0001800_abnormal_humoral_immune | 2.57719003 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.51512773 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.49978376 |
| 20 | MP0002419_abnormal_innate_immunity | 2.49834795 |
| 21 | MP0002723_abnormal_immune_serum | 2.42763756 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.42685558 |
| 23 | MP0001819_abnormal_immune_cell | 2.42276433 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.40321444 |
| 25 | MP0001529_abnormal_vocalization | 2.35648386 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.32487983 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 2.32253742 |
| 28 | MP0003303_peritoneal_inflammation | 2.32048630 |
| 29 | MP0008058_abnormal_DNA_repair | 2.29813263 |
| 30 | MP0005394_taste/olfaction_phenotype | 2.23131817 |
| 31 | MP0005499_abnormal_olfactory_system | 2.23131817 |
| 32 | MP0002006_tumorigenesis | 2.20775907 |
| 33 | MP0009379_abnormal_foot_pigmentation | 2.16439445 |
| 34 | MP0001905_abnormal_dopamine_level | 2.11216925 |
| 35 | MP0004043_abnormal_pH_regulation | 2.10606895 |
| 36 | MP0002653_abnormal_ependyma_morphology | 2.10128526 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 2.09654700 |
| 38 | MP0002405_respiratory_system_inflammati | 2.05668753 |
| 39 | MP0003136_yellow_coat_color | 2.04345518 |
| 40 | MP0006082_CNS_inflammation | 2.03124753 |
| 41 | MP0003718_maternal_effect | 2.01472627 |
| 42 | MP0003866_abnormal_defecation | 2.00721298 |
| 43 | MP0001873_stomach_inflammation | 1.99802768 |
| 44 | MP0005253_abnormal_eye_physiology | 1.97263714 |
| 45 | MP0002398_abnormal_bone_marrow | 1.91089847 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.90682320 |
| 47 | MP0006054_spinal_hemorrhage | 1.88509282 |
| 48 | MP0001486_abnormal_startle_reflex | 1.87099407 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.86596417 |
| 50 | MP0000716_abnormal_immune_system | 1.84543412 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.83843392 |
| 52 | MP0001853_heart_inflammation | 1.83808237 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.79903428 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.79159316 |
| 55 | MP0001968_abnormal_touch/_nociception | 1.77641059 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.77468453 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.73054600 |
| 58 | MP0002272_abnormal_nervous_system | 1.71580205 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.70672716 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 1.66000033 |
| 61 | MP0000490_abnormal_crypts_of | 1.65248287 |
| 62 | MP0004947_skin_inflammation | 1.63988636 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.62966986 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62762022 |
| 65 | MP0006276_abnormal_autonomic_nervous | 1.59903299 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.57774922 |
| 67 | MP0009745_abnormal_behavioral_response | 1.57332510 |
| 68 | MP0002102_abnormal_ear_morphology | 1.56746261 |
| 69 | MP0004510_myositis | 1.55358507 |
| 70 | MP0000858_altered_metastatic_potential | 1.53903255 |
| 71 | MP0002429_abnormal_blood_cell | 1.53636004 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 1.53421172 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.52621169 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.51185554 |
| 75 | MP0008872_abnormal_physiological_respon | 1.49804871 |
| 76 | MP0003011_delayed_dark_adaptation | 1.49682876 |
| 77 | MP0002722_abnormal_immune_system | 1.49648499 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.47356302 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.47356302 |
| 80 | MP0001764_abnormal_homeostasis | 1.43553695 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 1.43466548 |
| 82 | MP0004270_analgesia | 1.43421853 |
| 83 | MP0001970_abnormal_pain_threshold | 1.41428322 |
| 84 | MP0003693_abnormal_embryo_hatching | 1.41349197 |
| 85 | MP0009764_decreased_sensitivity_to | 1.40971834 |
| 86 | MP0002933_joint_inflammation | 1.39249823 |
| 87 | MP0008469_abnormal_protein_level | 1.38979178 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.38582718 |
| 89 | MP0001663_abnormal_digestive_system | 1.38216675 |
| 90 | MP0000372_irregular_coat_pigmentation | 1.35105135 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 1.33619543 |
| 92 | MP0005058_abnormal_lysosome_morphology | 1.29019629 |
| 93 | MP0004215_abnormal_myocardial_fiber | 1.28952669 |
| 94 | MP0004885_abnormal_endolymph | 1.28359365 |
| 95 | MP0005310_abnormal_salivary_gland | 1.27247725 |
| 96 | MP0002638_abnormal_pupillary_reflex | 1.25702222 |
| 97 | MP0004142_abnormal_muscle_tone | 1.25354179 |
| 98 | MP0000343_altered_response_to | 1.23180359 |
| 99 | MP0002572_abnormal_emotion/affect_behav | 1.22496491 |
| 100 | MP0006292_abnormal_olfactory_placode | 1.20996767 |
| 101 | MP0004957_abnormal_blastocyst_morpholog | 1.20037687 |
| 102 | MP0002064_seizures | 1.19497478 |
| 103 | MP0002090_abnormal_vision | 1.19464367 |
| 104 | MP0003448_altered_tumor_morphology | 1.17396659 |
| 105 | MP0001501_abnormal_sleep_pattern | 1.16485380 |
| 106 | MP0005360_urolithiasis | 1.16238007 |
| 107 | MP0005646_abnormal_pituitary_gland | 1.16208214 |
| 108 | MP0002733_abnormal_thermal_nociception | 1.15681692 |
| 109 | MP0000516_abnormal_urinary_system | 1.14923563 |
| 110 | MP0005367_renal/urinary_system_phenotyp | 1.14923563 |
| 111 | MP0002009_preneoplasia | 1.14109269 |
| 112 | MP0003186_abnormal_redox_activity | 1.13503083 |
| 113 | MP0010386_abnormal_urinary_bladder | 1.13330973 |
| 114 | MP0008004_abnormal_stomach_pH | 1.09908910 |
| 115 | MP0009046_muscle_twitch | 1.09310472 |
| 116 | MP0002822_catalepsy | 1.09248827 |
| 117 | MP0002998_abnormal_bone_remodeling | 1.08802844 |
| 118 | MP0005174_abnormal_tail_pigmentation | 1.07361184 |
| 119 | MP0005423_abnormal_somatic_nervous | 1.06788239 |
| 120 | MP0001502_abnormal_circadian_rhythm | 1.06558478 |
| 121 | MP0005332_abnormal_amino_acid | 1.06085840 |
| 122 | MP0004808_abnormal_hematopoietic_stem | 1.05456643 |
| 123 | MP0008877_abnormal_DNA_methylation | 1.05250157 |
| 124 | MP0001963_abnormal_hearing_physiology | 1.04743739 |
| 125 | MP0001986_abnormal_taste_sensitivity | 1.03408220 |
| 126 | MP0003828_pulmonary_edema | 1.02816935 |
| 127 | MP0002132_abnormal_respiratory_system | 1.02508239 |
| 128 | MP0002735_abnormal_chemical_nociception | 1.01633887 |
| 129 | MP0000703_abnormal_thymus_morphology | 1.01548292 |
| 130 | MP0010094_abnormal_chromosome_stability | 0.99570588 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.99256054 |
| 132 | MP0003635_abnormal_synaptic_transmissio | 0.98026514 |
| 133 | MP0002557_abnormal_social/conspecific_i | 0.96122608 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.95108325 |
| 135 | MP0004133_heterotaxia | 0.95100323 |
| 136 | MP0008932_abnormal_embryonic_tissue | 0.94788993 |
| 137 | MP0009278_abnormal_bone_marrow | 0.93655919 |
| 138 | MP0001958_emphysema | 0.93150704 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.91458963 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.90620281 |
| 141 | MP0000026_abnormal_inner_ear | 0.90597170 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.90539060 |
| 143 | MP0008007_abnormal_cellular_replicative | 0.90405240 |
| 144 | MP0009697_abnormal_copulation | 0.90387087 |
| 145 | MP0002233_abnormal_nose_morphology | 0.90261953 |
| 146 | MP0003786_premature_aging | 0.89747785 |
| 147 | MP0001664_abnormal_digestion | 0.89513798 |
| 148 | MP0005381_digestive/alimentary_phenotyp | 0.88676615 |
| 149 | MP0004147_increased_porphyrin_level | 0.88364030 |
| 150 | MP0001879_abnormal_lymphatic_vessel | 0.88007539 |
| 151 | MP0002139_abnormal_hepatobiliary_system | 0.87172238 |
| 152 | MP0001188_hyperpigmentation | 0.86649499 |
| 153 | MP0002067_abnormal_sensory_capabilities | 0.86275615 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.86245056 |
| 155 | MP0002938_white_spotting | 0.85274640 |
| 156 | MP0001293_anophthalmia | 0.84442086 |
| 157 | MP0003656_abnormal_erythrocyte_physiolo | 0.84421653 |
| 158 | MP0003075_altered_response_to | 0.82869919 |
| 159 | MP0000249_abnormal_blood_vessel | 0.82420599 |
| 160 | MP0001756_abnormal_urination | 0.81714955 |
| 161 | MP0001851_eye_inflammation | 0.81252758 |
| 162 | MP0005165_increased_susceptibility_to | 0.79804509 |
| 163 | MP0005390_skeleton_phenotype | 0.79253270 |
| 164 | MP0002163_abnormal_gland_morphology | 0.79071794 |
| 165 | MP0002234_abnormal_pharynx_morphology | 0.78512740 |
| 166 | MP0005195_abnormal_posterior_eye | 0.78462507 |
| 167 | MP0004859_abnormal_synaptic_plasticity | 0.77955901 |
| 168 | MP0003279_aneurysm | 0.77697543 |
| 169 | MP0002063_abnormal_learning/memory/cond | 0.77425981 |
| 170 | MP0006035_abnormal_mitochondrial_morpho | 0.77347306 |
| 171 | MP0000647_abnormal_sebaceous_gland | 0.77123492 |
| 172 | MP0002136_abnormal_kidney_physiology | 0.76793045 |
| 173 | MP0005166_decreased_susceptibility_to | 0.76460141 |
| 174 | MP0002909_abnormal_adrenal_gland | 0.75691060 |
| 175 | MP0003633_abnormal_nervous_system | 0.75077250 |
| 176 | MP0000631_abnormal_neuroendocrine_gland | 0.74681150 |
| 177 | MP0002877_abnormal_melanocyte_morpholog | 0.74106931 |
| 178 | MP0001542_abnormal_bone_strength | 0.73715476 |
| 179 | MP0009763_increased_sensitivity_to | 0.73148859 |
| 180 | MP0002095_abnormal_skin_pigmentation | 0.73139491 |
| 181 | MP0000778_abnormal_nervous_system | 0.72984437 |
| 182 | MP0002751_abnormal_autonomic_nervous | 0.72574643 |
| 183 | MP0000477_abnormal_intestine_morphology | 0.72371362 |
| 184 | MP0002282_abnormal_trachea_morphology | 0.72352429 |
| 185 | MP0009643_abnormal_urine_homeostasis | 0.65687354 |
| 186 | MP0003795_abnormal_bone_structure | 0.64274897 |
| 187 | MP0003183_abnormal_peptide_metabolism | 0.63004854 |
| 188 | MP0005164_abnormal_response_to | 0.62008223 |
| 189 | MP0005167_abnormal_blood-brain_barrier | 0.61553473 |
| 190 | MP0002019_abnormal_tumor_incidence | 0.60422699 |
| 191 | MP0002928_abnormal_bile_duct | 0.60310762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.31296142 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.08661326 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.97683346 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.56152578 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.33589357 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.30286834 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.26881249 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.22745700 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.21503161 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.14402636 |
| 11 | Acute encephalopathy (HP:0006846) | 4.12434314 |
| 12 | Myositis (HP:0100614) | 3.85860803 |
| 13 | Hepatic necrosis (HP:0002605) | 3.80001731 |
| 14 | Chronic otitis media (HP:0000389) | 3.79659373 |
| 15 | Increased CSF lactate (HP:0002490) | 3.77906744 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.67294613 |
| 17 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.54521545 |
| 18 | Petechiae (HP:0000967) | 3.53591461 |
| 19 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.52635841 |
| 20 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.52635841 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.45187123 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.45187123 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.38404149 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.37976680 |
| 25 | Abnormal ciliary motility (HP:0012262) | 3.37118041 |
| 26 | Rhinitis (HP:0012384) | 3.35517718 |
| 27 | Increased IgM level (HP:0003496) | 3.33919207 |
| 28 | Obstructive lung disease (HP:0006536) | 3.30164983 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30164983 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.28176942 |
| 31 | Stomatitis (HP:0010280) | 3.27703311 |
| 32 | Recurrent skin infections (HP:0001581) | 3.27602602 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 3.26060323 |
| 34 | Cerebral edema (HP:0002181) | 3.23874619 |
| 35 | Vasculitis (HP:0002633) | 3.16578165 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 3.16059573 |
| 37 | True hermaphroditism (HP:0010459) | 3.15587096 |
| 38 | Recurrent viral infections (HP:0004429) | 3.12630497 |
| 39 | Gait imbalance (HP:0002141) | 3.12351302 |
| 40 | Thrombocytosis (HP:0001894) | 3.10476016 |
| 41 | Orchitis (HP:0100796) | 3.10255509 |
| 42 | Lipid accumulation in hepatocytes (HP:0006561) | 3.09235267 |
| 43 | Congenital primary aphakia (HP:0007707) | 3.08425000 |
| 44 | IgM deficiency (HP:0002850) | 3.06862697 |
| 45 | Recurrent bronchitis (HP:0002837) | 3.06635524 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 3.04901104 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.04901104 |
| 48 | Meningitis (HP:0001287) | 3.02653086 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.93596461 |
| 50 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.93596461 |
| 51 | Pancreatic fibrosis (HP:0100732) | 2.89764185 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.88175666 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.84465181 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.83194915 |
| 55 | Optic neuritis (HP:0100653) | 2.83194915 |
| 56 | Pancreatic cysts (HP:0001737) | 2.82868719 |
| 57 | Respiratory failure (HP:0002878) | 2.82693686 |
| 58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.80324709 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79739380 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.79267466 |
| 61 | Abnormality of T cells (HP:0002843) | 2.78906364 |
| 62 | Severe combined immunodeficiency (HP:0004430) | 2.78904509 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.76747154 |
| 64 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74098754 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.73754543 |
| 66 | Cellulitis (HP:0100658) | 2.72607361 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.71040499 |
| 68 | Pustule (HP:0200039) | 2.69885953 |
| 69 | Lactic acidosis (HP:0003128) | 2.68658912 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.66117735 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.65533330 |
| 72 | Molar tooth sign on MRI (HP:0002419) | 2.65533330 |
| 73 | T lymphocytopenia (HP:0005403) | 2.65269011 |
| 74 | CNS demyelination (HP:0007305) | 2.64200213 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.61535610 |
| 76 | Eosinophilia (HP:0001880) | 2.61236310 |
| 77 | Hyperglycinemia (HP:0002154) | 2.60623162 |
| 78 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60356988 |
| 79 | Methylmalonic acidemia (HP:0002912) | 2.59899629 |
| 80 | Chronic bronchitis (HP:0004469) | 2.59798308 |
| 81 | Leukocytosis (HP:0001974) | 2.59434300 |
| 82 | Panhypogammaglobulinemia (HP:0003139) | 2.57681551 |
| 83 | Gingivitis (HP:0000230) | 2.53856104 |
| 84 | Type I transferrin isoform profile (HP:0003642) | 2.52060476 |
| 85 | Chronic diarrhea (HP:0002028) | 2.51909467 |
| 86 | Renal Fanconi syndrome (HP:0001994) | 2.50021685 |
| 87 | IgG deficiency (HP:0004315) | 2.49975265 |
| 88 | Purpura (HP:0000979) | 2.49835853 |
| 89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49808905 |
| 90 | Exertional dyspnea (HP:0002875) | 2.49801082 |
| 91 | Agammaglobulinemia (HP:0004432) | 2.47388180 |
| 92 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.47334096 |
| 93 | Leukodystrophy (HP:0002415) | 2.46847573 |
| 94 | Hyperactive renin-angiotensin system (HP:0000841) | 2.46464302 |
| 95 | Granulocytopenia (HP:0001913) | 2.45736495 |
| 96 | Increased serum lactate (HP:0002151) | 2.45681061 |
| 97 | Combined immunodeficiency (HP:0005387) | 2.45306755 |
| 98 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44465241 |
| 99 | Abnormality of glycine metabolism (HP:0010895) | 2.44465241 |
| 100 | Degeneration of anterior horn cells (HP:0002398) | 2.44237522 |
| 101 | Abnormality of the anterior horn cell (HP:0006802) | 2.44237522 |
| 102 | Hyperglycinuria (HP:0003108) | 2.43568173 |
| 103 | Abnormality of eosinophils (HP:0001879) | 2.43331913 |
| 104 | Gastrointestinal stroma tumor (HP:0100723) | 2.42568607 |
| 105 | B lymphocytopenia (HP:0010976) | 2.42189573 |
| 106 | Abnormality of B cell number (HP:0010975) | 2.42189573 |
| 107 | Lymphopenia (HP:0001888) | 2.42188123 |
| 108 | Lethargy (HP:0001254) | 2.41879139 |
| 109 | Hemoptysis (HP:0002105) | 2.41337333 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 2.39739723 |
| 111 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.39150403 |
| 112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.39134730 |
| 113 | Thyroiditis (HP:0100646) | 2.38999272 |
| 114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.37928149 |
| 115 | Optic disc pallor (HP:0000543) | 2.35859075 |
| 116 | Increased serum pyruvate (HP:0003542) | 2.35574353 |
| 117 | Abnormality of the prostate (HP:0008775) | 2.34553247 |
| 118 | Abnormal number of erythroid precursors (HP:0012131) | 2.33445110 |
| 119 | Gastrointestinal infarctions (HP:0005244) | 2.32886236 |
| 120 | Abnormal hemoglobin (HP:0011902) | 2.30550659 |
| 121 | Vertebral compression fractures (HP:0002953) | 2.30481322 |
| 122 | Nasal polyposis (HP:0100582) | 2.29683354 |
| 123 | Abnormality of vitamin B metabolism (HP:0004340) | 2.29067159 |
| 124 | Bronchiectasis (HP:0002110) | 2.28655391 |
| 125 | Metabolic alkalosis (HP:0200114) | 2.28273401 |
| 126 | Reticulocytopenia (HP:0001896) | 2.26142387 |
| 127 | Periodontitis (HP:0000704) | 2.24187978 |
| 128 | Urticaria (HP:0001025) | 2.23673119 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22140938 |
| 130 | Dicarboxylic aciduria (HP:0003215) | 2.22140938 |
| 131 | Myokymia (HP:0002411) | 2.21897739 |
| 132 | Pulmonary infiltrates (HP:0002113) | 2.21391766 |
| 133 | Nephronophthisis (HP:0000090) | 2.21359909 |
| 134 | Recurrent pneumonia (HP:0006532) | 2.18665796 |
| 135 | Exercise intolerance (HP:0003546) | 2.17937626 |
| 136 | Basal ganglia calcification (HP:0002135) | 2.17347927 |
| 137 | Congenital, generalized hypertrichosis (HP:0004540) | 2.17120763 |
| 138 | Genital tract atresia (HP:0001827) | 2.16623164 |
| 139 | Abnormality of renin-angiotensin system (HP:0000847) | 2.16130009 |
| 140 | Abnormality of serum amino acid levels (HP:0003112) | 2.15375251 |
| 141 | Increased muscle lipid content (HP:0009058) | 2.14883447 |
| 142 | Colon cancer (HP:0003003) | 2.14755353 |
| 143 | Abnormality of glycolysis (HP:0004366) | 2.14280765 |
| 144 | Vaginal atresia (HP:0000148) | 2.14079178 |
| 145 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.13771489 |
| 146 | Epistaxis (HP:0000421) | 2.13610276 |
| 147 | Emotional lability (HP:0000712) | 2.12862249 |
| 148 | Encephalitis (HP:0002383) | 2.12351118 |
| 149 | Osteomyelitis (HP:0002754) | 2.10085753 |
| 150 | Sepsis (HP:0100806) | 2.07222387 |
| 151 | Abnormal protein glycosylation (HP:0012346) | 2.06269840 |
| 152 | Abnormal glycosylation (HP:0012345) | 2.06269840 |
| 153 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06269840 |
| 154 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06269840 |
| 155 | Occipital encephalocele (HP:0002085) | 2.05025750 |
| 156 | Spontaneous hematomas (HP:0007420) | 2.04407134 |
| 157 | Posterior subcapsular cataract (HP:0007787) | 2.03412605 |
| 158 | Inflammation of the large intestine (HP:0002037) | 2.01710114 |
| 159 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01402540 |
| 160 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.01245781 |
| 161 | Cerebral hypomyelination (HP:0006808) | 2.00701133 |
| 162 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00152010 |
| 163 | Fatigue (HP:0012378) | 1.99465804 |
| 164 | Arterial thrombosis (HP:0004420) | 1.98768181 |
| 165 | Skin ulcer (HP:0200042) | 1.97754331 |
| 166 | Prostate neoplasm (HP:0100787) | 1.96326148 |
| 167 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.96220010 |
| 168 | Sclerocornea (HP:0000647) | 1.95530957 |
| 169 | Median cleft lip (HP:0000161) | 1.93023470 |
| 170 | IgA deficiency (HP:0002720) | 1.92429587 |
| 171 | Aplastic anemia (HP:0001915) | 1.92416151 |
| 172 | Postaxial foot polydactyly (HP:0001830) | 1.91624406 |
| 173 | Neutropenia (HP:0001875) | 1.89971936 |
| 174 | Keratoconjunctivitis sicca (HP:0001097) | 1.88669421 |
| 175 | Skin rash (HP:0000988) | 1.88191957 |
| 176 | Microcytic anemia (HP:0001935) | 1.88162304 |
| 177 | Increased hepatocellular lipid droplets (HP:0006565) | 1.87331897 |
| 178 | Abnormality of magnesium homeostasis (HP:0004921) | 1.84749410 |
| 179 | Hemiparesis (HP:0001269) | 1.81112852 |
| 180 | Broad foot (HP:0001769) | 1.80583432 |
| 181 | Hyperaldosteronism (HP:0000859) | 1.80234172 |
| 182 | Abnormality of the labia minora (HP:0012880) | 1.79951572 |
| 183 | Hypomagnesemia (HP:0002917) | 1.77329969 |
| 184 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77079109 |
| 185 | Abnormality of urine glucose concentration (HP:0011016) | 1.73544084 |
| 186 | Glycosuria (HP:0003076) | 1.73544084 |
| 187 | Postaxial hand polydactyly (HP:0001162) | 1.72990304 |
| 188 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.70227161 |
| 189 | Abolished electroretinogram (ERG) (HP:0000550) | 1.68914129 |
| 190 | Increased circulating renin level (HP:0000848) | 1.68304224 |
| 191 | Neoplasm of the adrenal gland (HP:0100631) | 1.68144514 |
| 192 | Delayed CNS myelination (HP:0002188) | 1.67519865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.39640903 |
| 2 | TXK | 3.24667218 |
| 3 | NME2 | 3.16029506 |
| 4 | VRK2 | 3.03658725 |
| 5 | MAP3K14 | 3.03176857 |
| 6 | MST4 | 2.80982974 |
| 7 | BLK | 2.75526510 |
| 8 | JAK3 | 2.59310843 |
| 9 | TBK1 | 2.49836214 |
| 10 | IRAK4 | 2.46583453 |
| 11 | IKBKE | 2.43123860 |
| 12 | BUB1 | 2.41486775 |
| 13 | MAP4K2 | 2.41385451 |
| 14 | TEC | 2.38273796 |
| 15 | PIM2 | 2.28906449 |
| 16 | KDR | 2.19123141 |
| 17 | ZAP70 | 2.12647342 |
| 18 | TYK2 | 2.04716818 |
| 19 | SRPK1 | 1.98911375 |
| 20 | MAP3K12 | 1.98665357 |
| 21 | NEK1 | 1.97921134 |
| 22 | PDK2 | 1.92587960 |
| 23 | BCKDK | 1.90239455 |
| 24 | KIT | 1.88529015 |
| 25 | TRIM28 | 1.85007166 |
| 26 | BTK | 1.79671078 |
| 27 | TESK1 | 1.77990736 |
| 28 | IRAK3 | 1.75894734 |
| 29 | IKBKB | 1.75483041 |
| 30 | ZAK | 1.63716191 |
| 31 | CSNK1G3 | 1.63128922 |
| 32 | TESK2 | 1.58067665 |
| 33 | RIPK4 | 1.56585802 |
| 34 | NME1 | 1.49333293 |
| 35 | WNK3 | 1.48733028 |
| 36 | MYLK | 1.47709898 |
| 37 | CSNK1G2 | 1.47185495 |
| 38 | BCR | 1.46302551 |
| 39 | ACVR1B | 1.44084314 |
| 40 | EPHA4 | 1.40085093 |
| 41 | CSNK1G1 | 1.39023103 |
| 42 | JAK1 | 1.38618152 |
| 43 | PRKG2 | 1.38098216 |
| 44 | LRRK2 | 1.37603349 |
| 45 | SYK | 1.35905217 |
| 46 | CSK | 1.35144389 |
| 47 | LIMK1 | 1.33694401 |
| 48 | ITK | 1.33591705 |
| 49 | CCNB1 | 1.31569074 |
| 50 | CSNK1A1L | 1.30182818 |
| 51 | NLK | 1.27797842 |
| 52 | ERBB3 | 1.27339502 |
| 53 | CASK | 1.26792687 |
| 54 | LCK | 1.26407497 |
| 55 | STK10 | 1.23505163 |
| 56 | PLK3 | 1.18368159 |
| 57 | NEK9 | 1.17848986 |
| 58 | PINK1 | 1.17827498 |
| 59 | DYRK2 | 1.15063196 |
| 60 | EPHB1 | 1.13268362 |
| 61 | OXSR1 | 1.11695876 |
| 62 | TSSK6 | 1.10923626 |
| 63 | MKNK1 | 1.09283652 |
| 64 | TLK1 | 1.06963944 |
| 65 | NTRK2 | 1.06272097 |
| 66 | MATK | 1.05203622 |
| 67 | MAPK15 | 1.04317819 |
| 68 | LYN | 1.02598037 |
| 69 | TTK | 1.02471880 |
| 70 | ERN1 | 1.02353036 |
| 71 | PLK2 | 1.00984828 |
| 72 | DAPK1 | 0.98722907 |
| 73 | PIM1 | 0.95724057 |
| 74 | FGFR4 | 0.95172745 |
| 75 | TGFBR2 | 0.94985661 |
| 76 | GRK6 | 0.93707433 |
| 77 | STK39 | 0.90882155 |
| 78 | TRPM7 | 0.90805071 |
| 79 | RPS6KA4 | 0.89776265 |
| 80 | GRK1 | 0.89104416 |
| 81 | FES | 0.87956350 |
| 82 | FLT3 | 0.87558520 |
| 83 | CLK1 | 0.85894658 |
| 84 | PBK | 0.85208375 |
| 85 | MAP3K13 | 0.85137727 |
| 86 | MKNK2 | 0.84731594 |
| 87 | HCK | 0.84501116 |
| 88 | PIK3CG | 0.84064862 |
| 89 | CDC7 | 0.83475005 |
| 90 | CSF1R | 0.82507397 |
| 91 | ERBB4 | 0.81968241 |
| 92 | TAOK3 | 0.79671699 |
| 93 | SIK3 | 0.79012760 |
| 94 | MAPK13 | 0.78432837 |
| 95 | MINK1 | 0.78377151 |
| 96 | TNIK | 0.78327319 |
| 97 | TIE1 | 0.77973054 |
| 98 | STK16 | 0.77896561 |
| 99 | MAP2K2 | 0.77737312 |
| 100 | CHUK | 0.76247175 |
| 101 | EPHA3 | 0.73050356 |
| 102 | IRAK1 | 0.73038234 |
| 103 | MAP2K7 | 0.72626592 |
| 104 | ARAF | 0.72497285 |
| 105 | RPS6KA5 | 0.72042759 |
| 106 | CAMK2G | 0.71322253 |
| 107 | ADRBK2 | 0.71181299 |
| 108 | MAP2K3 | 0.70972156 |
| 109 | CDK8 | 0.70693889 |
| 110 | WEE1 | 0.68335545 |
| 111 | MARK1 | 0.68285969 |
| 112 | PIK3CA | 0.67554543 |
| 113 | MAP3K11 | 0.67120051 |
| 114 | * PLK1 | 0.67110760 |
| 115 | BRSK2 | 0.65598706 |
| 116 | CAMKK2 | 0.64352265 |
| 117 | PRKCQ | 0.63750347 |
| 118 | JAK2 | 0.63382832 |
| 119 | TGFBR1 | 0.62549180 |
| 120 | CAMK2D | 0.61926142 |
| 121 | MARK3 | 0.61529892 |
| 122 | MAP3K4 | 0.61355750 |
| 123 | EIF2AK3 | 0.60254787 |
| 124 | PRKCD | 0.60053591 |
| 125 | SCYL2 | 0.59957440 |
| 126 | PHKG1 | 0.59835857 |
| 127 | PHKG2 | 0.59835857 |
| 128 | MAPKAPK5 | 0.59368064 |
| 129 | CAMK2A | 0.59199318 |
| 130 | PKN1 | 0.59155024 |
| 131 | EIF2AK1 | 0.57658009 |
| 132 | FGFR3 | 0.56885997 |
| 133 | PLK4 | 0.53075206 |
| 134 | STK38L | 0.52628462 |
| 135 | MST1R | 0.51974832 |
| 136 | PRKCE | 0.51974128 |
| 137 | BMPR2 | 0.51346057 |
| 138 | MAPKAPK2 | 0.51303564 |
| 139 | CSNK1A1 | 0.50522275 |
| 140 | VRK1 | 0.49962672 |
| 141 | PAK6 | 0.49657463 |
| 142 | MET | 0.49369244 |
| 143 | YES1 | 0.47986572 |
| 144 | INSRR | 0.47907602 |
| 145 | UHMK1 | 0.47811534 |
| 146 | NEK6 | 0.47476072 |
| 147 | AURKB | 0.47255695 |
| 148 | MAP3K1 | 0.44983843 |
| 149 | ROCK2 | 0.44754094 |
| 150 | EPHA2 | 0.44276054 |
| 151 | CDK19 | 0.43990752 |
| 152 | CAMK2B | 0.43290931 |
| 153 | LMTK2 | 0.41963209 |
| 154 | NUAK1 | 0.41644081 |
| 155 | NTRK3 | 0.41466159 |
| 156 | FRK | 0.40743960 |
| 157 | CSNK2A1 | 0.40360584 |
| 158 | BRSK1 | 0.40228298 |
| 159 | MAP2K6 | 0.39126822 |
| 160 | EIF2AK2 | 0.38637885 |
| 161 | BMPR1B | 0.37729024 |
| 162 | ABL1 | 0.37528704 |
| 163 | MUSK | 0.35140643 |
| 164 | PAK4 | 0.35055274 |
| 165 | ILK | 0.34870168 |
| 166 | ABL2 | 0.33952623 |
| 167 | MAPK4 | 0.33876047 |
| 168 | MAPK11 | 0.32891758 |
| 169 | DAPK3 | 0.32541038 |
| 170 | MAP3K8 | 0.31932304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.05143501 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63094010 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62895492 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.58274443 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.54530602 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54475584 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.41244874 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.39678124 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20080121 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18459544 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.09666179 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.05972674 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00939882 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99102758 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88685749 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.87569805 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84643624 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82284114 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79565423 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73623980 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71896580 |
| 22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.71107224 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.70438035 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69736123 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.67171222 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.65621730 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.60816494 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60607276 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57719547 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57038975 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56662430 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.51501618 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51211797 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.50180192 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50071536 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.48852520 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45146580 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42942534 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42480382 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41480939 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40083110 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40045792 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38809938 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38738991 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37438489 |
| 46 | Proteasome_Homo sapiens_hsa03050 | 1.37413881 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36272192 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33601443 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32763759 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.31455323 |
| 51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31320904 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31258349 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30707884 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30127603 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.27870899 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27463831 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.24781585 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 1.24209477 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23624924 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.22520757 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21870011 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21094329 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.20297840 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19089601 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17147606 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.15403649 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13668228 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13302226 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13071200 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.12076094 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 1.10656946 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10203180 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08666181 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.08612867 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03996151 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03639698 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03277312 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03195094 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01932623 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01743948 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99011741 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.98949596 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98920753 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98792700 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.98657072 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98470344 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97349259 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97323634 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95808300 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95396902 |
| 91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94666556 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94578599 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.92699693 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92186417 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.90939661 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90564691 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.90231513 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89660050 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87202678 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.87053488 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.85762111 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82540938 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81456374 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81349105 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80800995 |
| 106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78971513 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77945178 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77762478 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77500434 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77082755 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76467675 |
| 112 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76440463 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.76007056 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75570474 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.74581404 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74432728 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72770838 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72667340 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72660800 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71323548 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68448390 |
| 122 | Nicotine addiction_Homo sapiens_hsa05033 | 0.67853818 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64381540 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62600011 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62121404 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61685697 |
| 127 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60242841 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59991149 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.57825967 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57751427 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56221413 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55477646 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55217541 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55031053 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54517029 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53529568 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50320417 |
| 138 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49150986 |
| 139 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48868820 |
| 140 | RNA transport_Homo sapiens_hsa03013 | 0.47986853 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47854439 |
| 142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47539654 |
| 143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46795006 |
| 144 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46561508 |
| 145 | Phototransduction_Homo sapiens_hsa04744 | 0.45737784 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45363766 |
| 147 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44096931 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43675404 |
| 149 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42334300 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41334570 |
| 151 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40535547 |
| 152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40271653 |
| 153 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38907660 |
| 154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38520692 |
| 155 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38249398 |
| 156 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37712975 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37667962 |
| 158 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37234776 |
| 159 | Base excision repair_Homo sapiens_hsa03410 | 0.36816892 |
| 160 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36163729 |
| 161 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35560480 |
| 162 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35313286 |
| 163 | Homologous recombination_Homo sapiens_hsa03440 | 0.35312544 |
| 164 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34695538 |
| 165 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34457911 |
| 166 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33467182 |
| 167 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33007733 |
| 168 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31266686 |
| 169 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30923263 |

